Last reviewed · How we verify
Hypercalcemia due to Primary Hyperparathyroidism
Approved treatments
- Sensipar · Amgen
Sensipar works by activating the calcium-sensing receptor, which helps regulate calcium levels in the blood.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hypercalcemia due to Primary Hyperparathyroidism patent landscape — cliff calendar, originator estates, attackable patents
- Hypercalcemia due to Primary Hyperparathyroidism treatment landscape brief
- Hypercalcemia due to Primary Hyperparathyroidism treatment updates RSS
Frequently asked questions about Hypercalcemia due to Primary Hyperparathyroidism
What drugs treat Hypercalcemia due to Primary Hyperparathyroidism?
Tracked treatments include Sensipar.
What is the treatment for Hypercalcemia due to Primary Hyperparathyroidism?
Standard treatment for Hypercalcemia due to Primary Hyperparathyroidism includes Sensipar. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hypercalcemia due to Primary Hyperparathyroidism patent cliff · Hypercalcemia due to Primary Hyperparathyroidism CI report
- Treatment: Sensipar · Amgen
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing